# Bioavailability Evaluation of CurQ+ Curcumin Formulation

> **NCT06177483** · NA · COMPLETED · sponsor: **ESM Technologies, LLC** · enrollment: 20 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DIETARY_SUPPLEMENT:** 95% curcumin extract powder
- **DIETARY_SUPPLEMENT:** curQ+ curcumin formulation

## Key facts

- **NCT ID:** NCT06177483
- **Lead sponsor:** ESM Technologies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-09-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177483, "Bioavailability Evaluation of CurQ+ Curcumin Formulation". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06177483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
